{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:58:56Z","timestamp":1784779136164,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41435-021-00134-8","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:02:56Z","timestamp":1621515776000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["HLA-DRB1, IRF5, and CD28 gene polymorphisms in Egyptian patients with rheumatoid arthritis: susceptibility and disease activity"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-1143","authenticated-orcid":false,"given":"Nora M.","family":"Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nillie","family":"Ezzeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany M.","family":"Ebaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-1885","authenticated-orcid":false,"given":"Dina M.","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab M.","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"134_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/ard.56.5.313","volume":"56","author":"T Imanaka","year":"1997","unstructured":"Imanaka T, Shichikawa K, Inoue K, Shimaoka Y, Takenaka Y, Wakitani S. Increase in age at onset of rheumatoid arthritis in Japan over a 30 year period. Ann Rheum Dis. 1997;56:313\u20136.","journal-title":"Ann Rheum Dis"},{"key":"134_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1139\/o06-204","volume":"85","author":"L Lin","year":"2007","unstructured":"Lin L, Chen Y, Xiao Z, Huang S, Yang Z. The association of HLA-DRB1 alleles with rheumatoid arthritis in the Chinese Shantou population: a follow-up study. Biochem Cell Biol. 2007;85:227\u201338.","journal-title":"Biochem Cell Biol"},{"key":"134_CR3","doi-asserted-by":"publisher","first-page":"e18218","DOI":"10.1097\/MD.0000000000018218","volume":"98","author":"S Oka","year":"2019","unstructured":"Oka S, Furukawa H, Shimada K, Hashimoto A, Komiya A, Tsunoda S, et al. Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations. Medicine. 2019;98:e18218.","journal-title":"Medicine"},{"key":"134_CR4","doi-asserted-by":"crossref","unstructured":"Raslan HM, Attia HR, Hamed Ibrahim M, Mahmoud Hassan E, Salama, II, Ismail S, et al. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients. Int J Rheum Dis. 2020;23:647\u201353.","DOI":"10.1111\/1756-185X.13819"},{"key":"134_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10067-016-3496-2","volume":"36","author":"K Luterek-Puszy\u0144ska","year":"2017","unstructured":"Luterek-Puszy\u0144ska K, Malinowski D, Paradowska-Gorycka A, Safranow K, Pawlik A. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis. Clin Rheumatol. 2017;36:1129\u201335.","journal-title":"Clin Rheumatol"},{"key":"134_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0889-857X(03)00111-X","volume":"30","author":"MK Crow","year":"2004","unstructured":"Crow MK. Costimulatory molecules and T-cell-B-cell interactions. Rheum Dis Clin North Am. 2004;30:175\u201391.","journal-title":"Rheum Dis Clin North Am"},{"key":"134_CR7","doi-asserted-by":"publisher","first-page":"e0153316","DOI":"10.1371\/journal.pone.0153316","volume":"11","author":"L Vernerova","year":"2016","unstructured":"Vernerova L, Spoutil F, Vlcek M, Krskova K, Penesova A, Meskova M, et al. A combination of CD28 (rs1980422) and IRF5 (rs10488631) polymorphisms is associated with seropositivity in rheumatoid arthritis: a case control study. PLoS ONE. 2016;11:e0153316.","journal-title":"PLoS ONE"},{"key":"134_CR8","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/ard.2011.150326","volume":"70","author":"BW Higgs","year":"2011","unstructured":"Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, et al. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis. 2011;70:2029\u201336.","journal-title":"Ann Rheum Dis"},{"key":"134_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38:550\u20135.","journal-title":"Nat Genet"},{"key":"134_CR10","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/ar4608","volume":"16","author":"M Garc\u00eda-Berm\u00fadez","year":"2014","unstructured":"Garc\u00eda-Berm\u00fadez M, L\u00f3pez-Mej\u00edas R, Genre F, Casta\u00f1eda S, Llorca J, Gonz\u00e1lez-Juanatey C, et al. Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. Arthritis Res Ther. 2014;16:R146.","journal-title":"Arthritis Res Ther"},{"key":"134_CR11","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.3899\/jrheum.110322","volume":"38","author":"C Wang","year":"2011","unstructured":"Wang C, Kokkonen H, Sandling JK, Johansson M, Seddighzadeh M, Padyukov L, et al. Preferential association of interferon regulatory factor 5 gene variants with seronegative rheumatoid arthritis in 2 Swedish case-control studies. J Rheumatol. 2011;38:2130\u20132.","journal-title":"J Rheumatol"},{"key":"134_CR12","doi-asserted-by":"publisher","first-page":"e000448","DOI":"10.1136\/rmdopen-2017-000448","volume":"3","author":"PA Juge","year":"2017","unstructured":"Juge PA, Gazal S, Constantin A, Mariette X, Combe B, Tebib J, et al. Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis. RMD Open. 2017;3:e000448.","journal-title":"RMD Open"},{"key":"134_CR13","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1136\/ard.2006.063412","volume":"66","author":"TC van der Pouw Kraan","year":"2007","unstructured":"van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis. 2007;66:1008\u201314.","journal-title":"Ann Rheum Dis"},{"key":"134_CR14","doi-asserted-by":"publisher","first-page":"e31584","DOI":"10.1371\/journal.pone.0031584","volume":"7","author":"P Prasad","year":"2012","unstructured":"Prasad P, Kumar A, Gupta R, Juyal RC, Thelma BK. Caucasian and Asian specific rheumatoid arthritis risk loci reveal limited replication and apparent allelic heterogeneity in north Indians. PLoS ONE. 2012;7:e31584.","journal-title":"PLoS ONE"},{"key":"134_CR15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1515\/CCLM.2010.074","volume":"48","author":"YO Kim","year":"2010","unstructured":"Kim YO, Kim HJ, Kim SK, Chung JH, Hong SJ. Association of the CD28\/CTLA4\/ICOS polymorphisms with susceptibility to rheumatoid arthritis. Clin Chem Lab Med. 2010;48:345\u201353.","journal-title":"Clin Chem Lab Med"},{"key":"134_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1155\/2011\/620849","volume":"30","author":"IY Ledezma-Lozano","year":"2011","unstructured":"Ledezma-Lozano IY, Padilla-Mart\u00ednez JJ, Leyva-Torres SD, Parra-Rojas I, Ram\u00edrez-Due\u00f1as MG, Pereira-Su\u00e1rez AL, et al. Association of CD28 IVS3 +17T\/C polymorphism with soluble CD28 in rheumatoid arthritis. Dis Markers. 2011;30:25\u20139.","journal-title":"Dis Markers"},{"key":"134_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ng.479","volume":"41","author":"S Raychaudhuri","year":"2009","unstructured":"Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, et al. Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk. Nat Genet. 2009;41:1313\u20138.","journal-title":"Nat Genet"},{"key":"134_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/art.24135","volume":"60","author":"B Ding","year":"2009","unstructured":"Ding B, Padyukov L, Lundstr\u00f6m E, Seielstad M, Plenge RM, Oksenberg JR, et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 2009;60:30\u20138.","journal-title":"Arthritis Rheum"},{"key":"134_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00281-017-0630-4","volume":"39","author":"S Viatte","year":"2017","unstructured":"Viatte S, Barton A. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Semin Immunopathol. 2017;39:395\u2013408.","journal-title":"Semin Immunopathol"},{"key":"134_CR20","unstructured":"Imboden JB, Hellmann DB, Stone JH. Current diagnosis and treatment. 2013."},{"key":"134_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138.","journal-title":"Arthritis Rheum"},{"key":"134_CR22","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.2217\/ijr.13.24","volume":"8","author":"F Salaffi","year":"2013","unstructured":"Salaffi F, Ciapetti A. Clinical disease activity assessments in rheumatoid arthritis. Int J Clin Rheumatol. 2013;8:1758\u20134272.","journal-title":"Int J Clin Rheumatol"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41435-021-00134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-021-00134-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-021-00134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T23:42:06Z","timestamp":1699054926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-021-00134-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1038\/s41435-021-00134-8","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}